15 March 2024
Foresight Solar Fund Limited
(the "Company")
Director / PDMR Notification
The Company announces that Chris Ambler, Senior Independent Director and Non-Executive Director of the Company, being a person discharging managerial responsibilities ("PDMR"), has, on 14 March 2024, acquired 11,129 Ordinary Shares in the Company at a price of 89.8 pence per share.
In total, Chris Ambler has an interest in 62,820 Ordinary Shares, representing approximately 0.0103% of the Company's issued Ordinary Share Capital.
PDMR Notification Form:
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further details:
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA") | |||||
| a) | Name | Christopher John Ambler | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | PDMR | ||||
| b) | Initial notification/amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Foresight Solar Fund Limited | ||||
| b) | LEI | 213800VO4O83JVSSOX33 | ||||
| 4. | Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares | ||||
| Identification code | JE00BD3QJR55 | |||||
| b) | Nature of the Transaction | Acquisition of Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information | 11,129 ordinary shares in aggregate | ||||
| e) | Date of the transaction | 14 March 2024 | ||||
| f) | Place of the transaction | London Stock Exchange | ||||
ENDS
| Foresight Group | +44 (0)20 3667 8147 |
| JTC (Jersey) Limited | +44 (0)203 846 9774 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
